# Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products, Division 3: Quantitative particulars

Extent: E+W+S+N.I.

In order to give the ‘ quantitative particulars ’ of the active substances of an immunological veterinary medicinal product, it is necessary to specify whenever possible the number of organisms, the specific protein content, the mass, the number of International Units (IU) or units of biological activity, either per dosage-unit or volume, and with regard to the adjuvant and to the constituents of the excipients, the mass or the volume of each of them, with due allowance for the details provided in Section B.
Where an international unit of biological activity has been defined, this shall be used.
The units of biological activity for which no published data exist shall be expressed in such a way as to provide unambiguous information on the activity of the ingredients, e.g. by stating the immunological effect on which the method of determining the dose is based.

---
Source: https://www.legislation.gov.uk/eudr/2001/82/annex/I/title/II/part/2/division/A/division/3 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-82/annex-I/title-II/part-2/division-A/division-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.